DE69636346D1 - MIMOTOPE UND ANTIMIMOTOPE DES MENSCHLICHEN PLÄTTCHEN-GLYKOPROTEINS Ib/IX - Google Patents

MIMOTOPE UND ANTIMIMOTOPE DES MENSCHLICHEN PLÄTTCHEN-GLYKOPROTEINS Ib/IX

Info

Publication number
DE69636346D1
DE69636346D1 DE69636346T DE69636346T DE69636346D1 DE 69636346 D1 DE69636346 D1 DE 69636346D1 DE 69636346 T DE69636346 T DE 69636346T DE 69636346 T DE69636346 T DE 69636346T DE 69636346 D1 DE69636346 D1 DE 69636346D1
Authority
DE
Germany
Prior art keywords
mimotopes
peptide
molecule
mimotope
monoclonal antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69636346T
Other languages
English (en)
Other versions
DE69636346T2 (de
Inventor
L Miller
A Lyle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RCBT SERIES II LLC
Original Assignee
RCBT SERIES II LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RCBT SERIES II LLC filed Critical RCBT SERIES II LLC
Application granted granted Critical
Publication of DE69636346D1 publication Critical patent/DE69636346D1/de
Publication of DE69636346T2 publication Critical patent/DE69636346T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
DE69636346T 1995-11-13 1996-11-08 MIMOTOPE UND ANTIMIMOTOPE DES MENSCHLICHEN PLÄTTCHEN-GLYKOPROTEINS Ib/IX Expired - Lifetime DE69636346T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/556,597 US5877155A (en) 1995-03-17 1995-11-13 Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX
US556597 1995-11-13
PCT/US1996/017882 WO1997018236A1 (en) 1995-11-13 1996-11-08 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX

Publications (2)

Publication Number Publication Date
DE69636346D1 true DE69636346D1 (de) 2006-08-24
DE69636346T2 DE69636346T2 (de) 2007-08-09

Family

ID=24222017

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636346T Expired - Lifetime DE69636346T2 (de) 1995-11-13 1996-11-08 MIMOTOPE UND ANTIMIMOTOPE DES MENSCHLICHEN PLÄTTCHEN-GLYKOPROTEINS Ib/IX

Country Status (7)

Country Link
US (1) US5877155A (de)
EP (1) EP0876396B1 (de)
JP (1) JP3979448B2 (de)
CN (1) CN1140536C (de)
AT (1) ATE332914T1 (de)
DE (1) DE69636346T2 (de)
WO (1) WO1997018236A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074888B1 (en) * 1995-03-17 2006-07-11 The Research Foundation Of State University Of New York Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX
US6528061B1 (en) * 1997-09-04 2003-03-04 Pasteur Institut Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
EP1047707A1 (de) * 1998-01-23 2000-11-02 Ludwig Institute For Cancer Research Isolierte polypeptide die hla-a29 moleküle binden, nukleinsäuren, moleküle die diese kodieren und deren verwendung
US20020029391A1 (en) * 1998-04-15 2002-03-07 Claude Geoffrey Davis Epitope-driven human antibody production and gene expression profiling
US7481999B2 (en) 1998-05-05 2009-01-27 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin-mediated function
EP1084253A1 (de) * 1998-06-12 2001-03-21 Aventis Pasteur Mimotope des hiv virus
IL137121A0 (en) * 1998-10-30 2001-06-14 Miller Jonathan L Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
US7112661B1 (en) 1998-10-30 2006-09-26 The Research Foundation Of State University Of New York Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein Ib alpha
WO2001042281A1 (en) * 1999-12-06 2001-06-14 Hôpital Sainte-Justine Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis
US6632616B2 (en) * 2000-03-16 2003-10-14 Duke University Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof
IL145926A0 (en) * 2001-10-15 2002-07-25 Mor Research Applic Ltd Peptide epitopes of mimotopes useful in immunomodulation
EP1545578A4 (de) 2002-08-28 2010-07-07 Immunex Corp Zusammensetzungen und verfahren zur behandlung von herz-kreislauf-erkrankungen
JP2006517789A (ja) * 2003-01-10 2006-08-03 アブリンクス エン．ヴェー． 治療用ポリペプチド、その相同物、その断片、および血小板媒介凝集の調節での使用
EP2133362B1 (de) 2003-07-25 2012-04-18 Amgen, Inc Verfahren bezüglich LDCAM und CRTAM
US20090181057A1 (en) 2004-05-04 2009-07-16 The Board Of Trustees Of The University Of Illinois Methods and Compositions for the Inhibition of Thrombus Formation
US20080015145A1 (en) 2006-07-11 2008-01-17 Maria Gyongyossy-Issa Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions
US20090304719A1 (en) 2007-08-22 2009-12-10 Patrick Daugherty Activatable binding polypeptides and methods of identification and use thereof
EP2108657A1 (de) 2008-04-08 2009-10-14 DKFZ Deutsches Krebsforschungszentrum Peptide zur HPV-E6-Onkoproteinhemmung
WO2009158432A2 (en) 2008-06-27 2009-12-30 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
WO2010081173A2 (en) 2009-01-12 2010-07-15 Cytomx Therapeutics, Llc Modified antibody compositions, methods of making and using thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114842A (en) * 1987-07-08 1992-05-19 The Scripps Research Institute Peptides and antibodies that inhibit platelet adhesion
US5340727A (en) * 1987-11-17 1994-08-23 The Scripps Research Institute GPIbα fragments and recombinant DNA expression vectors
US5177188A (en) * 1990-12-03 1993-01-05 The Scripps Research Institute Methods and compositions for diagnosing chronic immune thrombocytopenic purpura

Also Published As

Publication number Publication date
DE69636346T2 (de) 2007-08-09
EP0876396A4 (de) 1999-09-22
US5877155A (en) 1999-03-02
WO1997018236A1 (en) 1997-05-22
ATE332914T1 (de) 2006-08-15
CN1202175A (zh) 1998-12-16
EP0876396A1 (de) 1998-11-11
JP2001511111A (ja) 2001-08-07
EP0876396B1 (de) 2006-07-12
CN1140536C (zh) 2004-03-03
JP3979448B2 (ja) 2007-09-19

Similar Documents

Publication Publication Date Title
DE69636346D1 (de) MIMOTOPE UND ANTIMIMOTOPE DES MENSCHLICHEN PLÄTTCHEN-GLYKOPROTEINS Ib/IX
DE69737683D1 (de) Antikörper gegen die ed-b domäne von fibronektin, ihre herstellung und verwendungen
ATE218387T1 (de) Antikörperreinigung
DE60025832D1 (de) Mehrere zytokin-antikörper komplexen
PT724456E (pt) Anticorpos contra cd4
ATE215831T1 (de) Monoklonale antikörper, die an den vorläufer des tumorabstossantigen mage-1 anbinden, rekombinantes mage-1, und von mage-1 abgebieteteimmunogene peptide
DE69429095D1 (de) Humanisierte antikoerper
WO2002020569A3 (en) Mammalian genes; related reagents and methods
MX9304363A (es) Metodo para enlace intracelular de moleculas blanco.
SI1629011T1 (sl) Humane molekule za vezavo anti hu cd
HUP0202532A2 (hu) Ko-stimulátor szignál-transzdukciós molekula (AILIM) elleni humán monoklonális antitest és gyógyászati alkalmazása
ATE204480T1 (de) Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon
IL148113A0 (en) Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
DE69738138D1 (de) Induktion von immunologischer Toleranz gegen einen therapeutischen Antikörper durch Varianten des therapeutischen Antikörpers
ATE270303T1 (de) Gc1q-rezeptor, daran bindende hiv-1 gp120-region, verwandte peptide und antikörper
WO2002024222A3 (en) Ligands for g protein coupled receptors and methods of using them
TR200102493T2 (tr) IgE'nin C-epsilon-3 veya C-epsilon-4 alanlarından türetilmiş epitoplar veya mimotoplar.
PT877803E (pt) Receptor da proteina ob e composicoes e metodos afins
ATE182152T1 (de) Wachstumsfaktor-ligand, der an den erbb-2- rezeptor bindet und die zellulären reaktionen induziert
DE59809283D1 (de) Inhibitoren für den urokinaserezeptor
DE69611037D1 (de) Methadonderivate und protein- und polypeptid-methadonkonjugate und markierte verbindungen
ATE209041T1 (de) Durch hla-b44 moleküle präsentierte tumor- abstossungsantigene und ihre verwendung
BR9611851A (pt) Molécula de ácido nucléico isolada e purificada, vetor de experessão recombinatória, célula hospedeira contendo um vetor de expressão recombina tório, proteìnas tbpa e tbpb isolada e purificadas, método para preparar uma protéina tbpa e tbpb, anti-corpo policlÈnico ou monoclÈnico, e vacinas assim obtidas
SE9902899D0 (sv) New peptides, corresponding antibodies, and compositions thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition